A2 Milk sinks 11% as FDA defers new approvals

A2 Milk sinks 11% as FDA defers new approvals
Market disappointed with A2 news. (Image: Getty)
Rebecca Howard
A2 Milk sank 11% on news it won’t be sending infant formula to the lucrative US market any time soon.According to the company, the US Food and Drug Administration (FDA) is deferring further consideration of the company’s request for enforcement discretion to import infant milk formula products into the US.Last week, the company's shares jumped on an Australian news report that approval might be imminent. While A2 Milk moved quickly to dampen those expectations, the shares remained elevated, peaking at $5.64 on Friday.They recent...

More Primary Sector

Reducing farm emissions is about future proofing: Nestlé
Primary Sector

Reducing farm emissions is about future proofing: Nestlé

Dairy makes up 21% of Nestlé's scope 3 or 'on farm' emissions.

Rebecca Howard 04 Jul 2024
Jones heads to Oz to woo mining investors
Primary Sector

Jones heads to Oz to woo mining investors

Work has begun on a critical minerals list and stocktake.

Ian Llewellyn 03 Jul 2024